Averhealth’s lab practices have been faulted by its own accreditor, and the company has been targeted in lawsuits and dropped by two child welfare agencies, a ProPublica investigation found.
New Jersey Medicare patients will be guinea pigs in a grand experiment that tests the capabilities of using artificial intelligence to decide which medical procedures should be covered by insurance.
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...
Nvidia is allegedly testing software that can track the location of its AI chips as reports of its chips being smuggled into China are on the rise. Nvidia has built location verification technology ...
Product demos get all the attention, but software development more often involves things like debugging, quality assurance, and testing. It’s the dull but critical work that keeps software running the ...
What rules does the Trump administration’s new naturalization test change regarding the questions immigrants must answer? The U.S. Citizenship and Immigration Services (USCIS) issued an alert on ...
How long would you keep going to work if you didn’t receive a paycheck? That’s the question that thousands of air traffic controllers and TSA officers will be asking themselves as the federal ...
Syracuse, N.Y. – A 28-year-old Syracuse employee and a summer intern were up against a new deadline. They needed to collect at least 100 drinking water samples at residential properties for the city’s ...
FORT BELVOIR, Va. — PEO Enterprise’s Digital Market team has another newly negotiated enterprise license agreement under its belt, which will provide cost savings to Army customers. On Aug. 1, PEO ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. In this episode, Thomas Betts chats with ...
NI Nigel AI Advisor will transform how engineers approach test and measurement, cutting through complexity and accelerating workflows AUSTIN, Texas, July 22, 2025 /PRNewswire/ -- Emerson (NYSE: EMR), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results